Vandetanib Successfully Controls Medullary Thyroid Cancer-Related Cushing Syndrome in an Adolescent Patient | Zendy

Aikaterini A. Nella | Zendy; Maya Lodish | Zendy; Elizabeth Fox | Zendy; Frank M. Balis | Zendy; Martha Quezado | Zendy; Patricia Whitcomb | Zendy; Joanne Derdak | Zendy; Electron Kebebew | Zendy; Brigitte C. Widemann | Zendy; Constantine A. Stratakis | Zendy

AI Assistant Blog Pricing

Open Access

Vandetanib Successfully Controls Medullary Thyroid Cancer-Related Cushing Syndrome in an Adolescent Patient

Author(s) -

Aikaterini A. Nella,

Maya Lodish,

Elizabeth Fox,

Frank M. Balis,

Martha Quezado,

Patricia Whitcomb,

Joanne Derdak,

Electron Kebebew,

Brigitte C. Widemann,

Constantine A. Stratakis

Publication year - 2014

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2013-4340

Subject(s) - vandetanib , medicine , medullary thyroid cancer , endocrinology , cushing syndrome , tyrosine kinase inhibitor , oncology , thyroid cancer , cancer , tyrosine kinase , receptor

Ectopic Cushing syndrome due to ACTH secretion from metastatic medullary thyroid cancer (MTC) is associated with significant morbidity and mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog